BIOAF

Bioasis Technologies (QB) Stock Price

0.2505
0.00 (0.0%)
0.2505
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Bioasis Technologies Inc (QB) BIOAF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.2505 20:00:00
Close Price Low Price High Price Open Price Previous Close
0.2505
Bid Price Ask Price Spread News
0.236 0.268 0.032 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.2505 USD

Bioasis Technologies (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.02M 67.96M 67.57M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
303.00 $ - 0.00% - -

more financials information »

Bioasis Technologies (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIOAF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.27690.29390.211950.249649241,440-0.0264-9.53%
1 Month0.26550.340.211950.255868115,276-0.015-5.65%
3 Months0.222450.383250.211950.320196423,4770.0280512.61%
6 Months0.129590.383250.10730.26744623,8620.1209193.3%
1 Year0.14860.383250.0920.22790819,8750.101968.57%
3 Years0.74390.80550.0920.307867715,284-0.4934-66.33%
5 Years0.86411.550.0920.480829113,135-0.6136-71.01%

Bioasis Technologies (QB) Description

Bioasis Technologies Inc. is a biopharmaceutical company developing the xB platform, a proprietary technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the BBB represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders. The company maintains headquarters in Guilford, Conn., United States. Bioasis trades on the TSX Venture Exchange under the symbol "BTI" and on the OTCQB under the symbol "BIOAF." For more information about the company, please visit www.bioasis.us.


Your Recent History
USOTC
BIOAF
Bioasis Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.